tirzepatide in an antonio Specialist Near Me San Antonio, TX GLP-1 Program Overview (Tirzepatide &

The FDA Adverse Event Reporting System (FAERS) database was used to assess the association between GLP-1RAs and diabetic ketoacidosis/ketosis

The FDA labeling recommends considering dose reduction of insulin or sulfonylureas when initiating tirzepatide to mitigate this risk

Emergency medical services (911) should be contacted for any severe hypoglycemic episode

Semaglutide and tirzepatide are provider-prescribed GLP-1 medications that work by reducing appetite, regulating blood sugar, and helping your body burn fat more efficiently

Due to tirzepatide's long half-life (approximately five days) and delayed peak concentration (8-72 hours after injection), symptoms typically reflect steady-state effects rather than immediate post-injection peaks

Inadequate carbohydrate intake, irregular meal patterns, or increased physical activity without corresponding dietary adjustment can precipitate low blood sugar, especially in patients taking multiple glucose-lowering agents